{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:02:54Z","timestamp":1762016574461,"version":"build-2065373602"},"reference-count":11,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej19-0198","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T22:04:07Z","timestamp":1568325847000},"page":"31-35","source":"Crossref","is-referenced-by-count":8,"title":["Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab"],"prefix":"10.1507","volume":"67","author":[{"given":"Taisuke","family":"Uchida","sequence":"first","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinami","family":"Kushima","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadato","family":"Yonekawa","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Zheng GZ, Chang B, Lin FX, Xie D, Hu QX, et al. (2017) Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours. Eur J Cancer Care 26: e12541.","DOI":"10.1111\/ecc.12541"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, et al. (2012) Denosumab treatment for fibrous dysplasia. J Bone Miner Res 27: 1462\u20131470.","DOI":"10.1002\/jbmr.1603"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Grasemann C, Sch\u00fcndeln MM, H\u00f6vel M, Schweiger B, Bergmann C, et al. (2013) Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget\u2019s disease. J Clin Endocrinol Metab 98: 3121\u20133126.","DOI":"10.1210\/jc.2013-1143"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Gossai N, Hilgers MV, Polgreen LE, Greengard EG (2015) Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone. Pediatr Blood Cancer 62: 1078\u20131080.","DOI":"10.1002\/pbc.25393"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Setsu N, Kobayashi E, Asano N, Yasui N, Kawamoto H, et al. (2016) Severe hypercalcemia following denosumab treatment in a juvenile patient. J Bone Miner Metab 34: 118\u2013122.","DOI":"10.1007\/s00774-015-0677-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Koldkj\u00e6r S\u00f8lling AS, Harsl\u00f8f T, Kaal A, Rejnmark L, Langdahl B (2016) Hypercalcemia after discontinuation of long-term denosumab treatment. Osteoporos Int 27: 2383\u20132386.","DOI":"10.1007\/s00198-016-3535-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Fukumoto S, Yamashita T (2007) FGF23 is a hormone-regulating phosphate metabolism\u2014unique biological characteristics of FGF23. Bone 40: 1190\u20131195.","DOI":"10.1016\/j.bone.2006.12.062"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ozkaya HM, Keskin FE, Haliloglu OA, Senel TE, Kadioglu P (2015) Life-threatening hypercalcemia due to Graves\u2019 disease and concomitant adrenal failure: a case report and review of the literature. Case Rep Endocrinol 2015: 684648.","DOI":"10.1155\/2015\/684648"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Smith IE, Dowsett M (2003) Aromatase inhibitors in breast cancer. N Engl J Med 348: 2431\u20132442.","DOI":"10.1056\/NEJMra023246"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Guti\u00e9rrez OM (2010) Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the \u201cTrade-off\u201d hypothesis. Clin J Am Soc Nephrol 5: 1710\u20131716.","DOI":"10.2215\/CJN.02640310"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hu MC, Shiizaki K, Kuro-o M, Moe OW (2013) Fibroblast growth factor 23 and klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 75: 503\u2013533.","DOI":"10.1146\/annurev-physiol-030212-183727"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/1\/67_EJ19-0198\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T03:42:44Z","timestamp":1580528564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/1\/67_EJ19-0198\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0198","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"type":"print","value":"0918-8959"},{"type":"electronic","value":"1348-4540"}],"subject":[],"published":{"date-parts":[[2020]]}}}